GCP
IMPV

Garelick Capital Partners’s Imperva, Inc. IMPV Stock Holding History

Garelick Capital Partners’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-41,000
Closed -$2.6M – 32
2015
Q4 		$2.6M Buy
+41,000
New +$2.79M 2.29% 21

Other funds holding IMPV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Garelick Capital Partners's IMPV Position: Q1 2016 in Review

Garelick Capital Partners sold out of Imperva, Inc. (IMPV) in Q1 2016, closing a stake of 41,000 shares — an estimated $2.6M sold.

Garelick Capital Partners first reported a position in IMPV in Q4 2015 and held it in 1 quarter. The position peaked at $2.6M in Q4 2015. 160 funds tracked by Wall St. Rank hold IMPV as of Q1 2016.

  • Garelick Capital Partners reported no remaining Imperva, Inc. position as of Q1 2016 after selling out during the quarter.
  • Garelick Capital Partners sold 41,000 Imperva, Inc. shares in Q1 2016, an estimated $2.6M.
  • Garelick Capital Partners first reported a position in Imperva, Inc. in Q4 2015 and held it in 1 quarter.
  • Garelick Capital Partners's Imperva, Inc. position peaked at $2.6M in Q4 2015.
  • 160 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2016.

Based on Garelick Capital Partners's 13F filing for Q1 2016, filed 11 May 2016.